Effect of Liposomal-Lactoferrin-Based Eye Drops on the Conjunctival Microflora of Patients Undergoing Cataract

Giuseppe Giannaccare1, Sofia Comis2, Virginia Jannuzzi2

  • 1Department of Ophthalmology, University Magna Graecia of Catanzaro, Catanzaro, Italy. giuseppe.giannaccare@unicz.it.

Ophthalmology and Therapy
|February 24, 2023
PubMed
Abstract

Insights

Lactoferrin (LF)-based eye drops effectively reduced potentially pathogenic bacteria on the ocular surface before cataract surgery. This safe, selective treatment enhances natural defenses against bacterial contamination without altering normal flora.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Pharmacology

Background:

  • Postoperative endophthalmitis is a serious complication of cataract surgery, often caused by the patient's own bacterial flora.
  • Current perioperative antisepsis with povidone-iodine may be enhanced by strategies to reduce conjunctival microbial load.
  • Increasing antibiotic resistance necessitates exploring alternative prophylactic methods.

Purpose of the Study:

  • To evaluate the efficacy of lactoferrin (LF)-based eye drops in reducing conjunctival bacterial load prior to cataract surgery.
  • To assess the impact of LF-based eye drops on the ocular surface microflora composition.
  • To determine the safety profile of LF-based eye drops in this preoperative setting.

Main Methods:

  • A randomized controlled trial involving patients undergoing cataract surgery.
  • Preoperative administration of either LF-based eye drops or a vehicle solution four times daily for three days.
  • Conjunctival swabs collected before therapy (T0) and at surgery (T1) for microbial analysis, including growth, isolation, and species identification.

Main Results:

  • LF-based eye drops significantly reduced the proportion of potentially pathogenic bacteria from 36% at baseline to 9% at surgery (p=0.008).
  • The vehicle group showed an increase in potentially pathogenic bacteria from 41% to 55% (p=0.302).
  • LF treatment did not alter the physiological ocular microbial composition and was well-tolerated, with no adverse events reported.

Conclusions:

  • LF-based eye drops represent a safe and selective adjunctive treatment for controlling bacterial contamination on the ocular surface before cataract surgery.
  • This approach supports the ocular surface's physiological defenses and offers a promising alternative in the face of rising antibiotic resistance.
  • The findings contribute novel scientific insights into the role of lactoferrin in ophthalmic care.